Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Pregnancy milk showdown: could A2-Only milk ease tummy troubles?

NCT ID NCT06980376

Symptom relief Sponsor: a2 Milk Company Ltd. Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jul 08, 2026 · Updated 2 times

Summary

This study compares regular milk (containing A1 and A2 proteins) with milk that has only A2 protein in 100 healthy pregnant women. Researchers will measure gut symptoms, inflammation levels, and pregnancy outcomes from 12 weeks of pregnancy until 40 days after birth. The goal is to see if A2-only milk is easier on digestion and reduces inflammation during pregnancy.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 100 people

The number the study aims to enrol. It can still change while the study runs.

Started

Aug 2025

Expected to finish

Sep 2026

An estimate. End dates often move.

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

20 to 35 years

Sex

Female participants only

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * 20-35 years of age * Recruited at \<12 weeks of gestation * Intention to deliver at study site hospital * Singleton pregnancy * Able and willing to consume milk during pregnancy * Agree not to participate in another interventional clinical study during the present study Exclusion Criteria: * Body mass index ≥ 35 at enrolment * Cow's milk intolerance or allergy * Significant systemic disorder (e.g., cardiac, respiratory, endocrinological, hemato-logic, or GI); pre-pregnancy diabetes, hypertension, or other medical conditions that preclude participation per the investigator's judgement * Taking any prescribed chronic medications * Participation in another clinical trial * Investigator uncertainty about the willingness or ability of the participant to comply with the protocol requirements * Taking probiotics at screening or two weeks before enrolment * Receiving any vaccine at screening or two weeks before enrolment

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Healthy pregnant women are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Healthy pregnant women

Contacts and locations

Locations

  • Affiliated hospital of Jiangnan University

    Wuxi, Jiangsu, 214122, China

  • First People's Hospital of Chengdu

    Chengdu, Sichuan, 610041, China

  • Foshan Maternity & Child Healthcare Hospital

    Foshan, Guangdong, 528000, China

  • Panyu Maternal and Child Care Service Centre of Guangzhou

    Guangzhou, Guangdong, 511400, China

  • Wuxi Maternal and Child Health Hospital

    Wuxi, Jiangsu, 214002, China

  • Xuzhou Maternal and Child Health Hospital

    Xuzhou, Jiangsu, 221009, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.